Advertisement

Indian Journal of Surgery

, Volume 81, Issue 6, pp 520–524 | Cite as

Radical Mastectomy SANS Axillary Lymph Node Dissection for Large Phyllodes Tumor: a Guarantee Against Recurrence

  • Kamal Kataria
  • Anita Dhar
  • Piyush Ranjan
  • Atish Kumar
  • Sharmin Islam
  • Anurag SrivastavaEmail author
Original Article

Abstract

Phyllodes tumor of the breast is a rare mixed tumor of epithelial and mesenchymal origin with an incidence of less than 1% of all primary breast tumors. This tumor is well known for its high potential for local recurrence ranging in 8–40% of patients. Excision of tumor with a 2-cm margin without raising skin flap along with overlying skin and underlying part of pectoralis major muscle described by our team seems to be a guarantee against local recurrence. It was a prospective cohort study conducted at the Department of Surgical Disciplines, AIIMS, New Delhi, India, from March 2011 to December 2016. Patients with large phyllodes tumor were managed with a “radical mastectomy without axillary lymph node dissection” whereas women with a small lesion were treated with a wide local excision with a 2-cm margin of healthy breast tissue all around the lesion following our surgical technique. Sixty-one women were enrolled in this study. Twenty-nine patients underwent wide local excision, and 32 patients with large, recurrent, or malignant tumors were managed by radical mastectomy without axillary lymph node dissection (ALND) (27 patients) and with ALND in 5 patients with enlarged axillary nodes. None of the patients have developed local recurrence till date with a follow-up period ranging from 2 to 59 months. Excision of tumor with a 2-cm margin without raising skin flap along with overlying skin and underlying part of pectoralis major muscle is a very effective technique to prevent local recurrence.

Keywords

Phyllodes tumor Recurrence Radical mastectomy Wide local excision Myocutaneous flap 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 107:2127–2133CrossRefGoogle Scholar
  2. 2.
    Muller J (1838) Uber den feinern bau und die formen der krankhaften geschwulste, vol 1. Reimer, Berlin, pp 54–60Google Scholar
  3. 3.
    Parker SJ, Harries SA (2001) Phyllodes tumours. Postgrad Med J 77:428–435CrossRefGoogle Scholar
  4. 4.
    Hajdu SI, Espinosa MH, Robbins GF (1976) Recurrent cystosarcoma phyllodes: a clinicopathological study of 32 cases. Cancer 38:1402–1406CrossRefGoogle Scholar
  5. 5.
    Badwe RA, Kataria K, Srivastava A (2015) Surgical resection of phyllodes tumour: a radical approach as a safeguard against local recurrence. Indian J Surg 77(2):161–163CrossRefGoogle Scholar
  6. 6.
    Pietruszka M, Barnes L (1978) Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 41:1974–1983CrossRefGoogle Scholar
  7. 7.
    Azzopardi JG (1979) Problems in breast pathology. In: Bennington J (ed) Major progress in pathology. W.B. Saunders, Philadelphia, pp 346–365Google Scholar
  8. 8.
    Calhoun KE, Lawton TJ, Kim JN et al (2010) Phyllodes tumors. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 781–792Google Scholar
  9. 9.
    Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H (2003) Core needle biopsy as a diagnostic tool to differentiate phyllodes tumor from fibroadenoma. Arch Surg 138:987–990CrossRefGoogle Scholar
  10. 10.
    Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E (2016) Phyllodes tumours of the breast: a consensus review. Histopathology 68(1):5–21CrossRefGoogle Scholar
  11. 11.
    August DA, Kearney T (2000) Cystosarcoma phyllodes: mastectomy, lumpectomy, or lumpectomy plus irradiation. Surg Oncol 9:49–52CrossRefGoogle Scholar
  12. 12.
    Huang CC, Liu TP, Cheng SP, Cheng YC (2014) Surgical treatment of phyllodes tumor of breast with the trend. J Exp Clin Med 6(5):161–165CrossRefGoogle Scholar
  13. 13.
    Burton GV, Hart LL, Leight GS Jr (1989) Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer 63(11):2088–2092CrossRefGoogle Scholar
  14. 14.
    Telli ML, Horst KC, Guardino AE (2007) Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Cancer Netw 5(3):324–330CrossRefGoogle Scholar
  15. 15.
    Chaney AW, Pollack A, McNeese MD, Zagars GK (1998) Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Investig 6:264–267CrossRefGoogle Scholar
  16. 16.
    Barth RJ, Wells WA, Mitchell SE, Cole BF (2009) A prospective multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumours. Ann Surg Oncol 16(8):2288–2294CrossRefGoogle Scholar
  17. 17.
    Umekita Y, Yoshida H (1998) Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Arch 433:311–314CrossRefGoogle Scholar

Copyright information

© Association of Surgeons of India 2019

Authors and Affiliations

  1. 1.Department of Surgical DisciplinesAll India Institute of Medical SciencesNew DelhiIndia
  2. 2.Department of Casualty SurgeryDhaka Medical College HospitalDhakaBangladesh

Personalised recommendations